The organization’s board of directors declined to discuss details of the termination, citing employee confidentiality, the Gazette reported.
Dr. Gibb became CEO in July 2017, prior to being interim CEO and CMO. He joined Billings Clinic, a physician-led multispecialty group practice with a 304-bed hospital and a level 2 trauma center, in 2006, providing care as a gynecologic oncologist.
Billings Clinic named Robert Merchant, MD, and John Schallenkamp, MD, interim co-CEOs. Dr. Merchant is CMO of the organization and a practicing pulmonary, critical care and sleep medicine physician, while Dr. Schallenkamp is medical director of the Billings Clinic Cancer Center and a practicing radiation oncologist. Dr. Schallenkamp is also a member of Billings’ board.
Dr. Schallenkamp told the Gazette that the organization decided to appoint co-CEOs because both he and Dr. Merchant are still practicing.
“I would say it would be kind of difficult to drop our patients and practices,” he said, according to the report. “So together, we’re going to be able to fulfill all our requirements.”
The organization plans to select a single CEO as a permanent replacement for Dr. Gibb, Dr. Schallenkamp told the Gazette.
More articles on executive moves:
MD Anderson names Dr. David Jaffray 1st chief technology and digital officer
Massachusetts General Hospital appoints its first chief equity and inclusion officer
21 recent hospital, health system CNO and CMO moves
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
